Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP

Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan

(2010) Yoshihiro Miyake et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Serum cholesterol levels and the risk of multiple system atrophy: A case-control study

(2009) Phil Hyu Lee et al.   MOVEMENT DISORDERS

Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease

(2008) Michael A. Schwarzschild   ARCHIVES OF NEUROLOGY

Statins reduce neuronal α-synuclein aggregation in in vitro models of Parkinson’s disease

(2008) Pazit Bar-On et al.   JOURNAL OF NEUROCHEMISTRY

Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study

(2008) Xuemei Huang et al.   MOVEMENT DISORDERS

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

(2008) L. Dupuis et al.   NEUROLOGY

Total cholesterol and the risk of Parkinson disease

(2008) G. Hu et al.   NEUROLOGY